Buscador de publicacions

Publicacions

  • Rubio-San-Simón A, André N, Cefalo MG, Aerts I, Castañeda-Heredia A, Benezech S, Makin G, van Eijkelenburg N, Nysom K, Marshall L, Gambart M, Hladun R, Rossig C, Bergamaschi L, Fagioli F, Carpenter B, Ducassou S, Owens C, Øra I, Ribelles AJ, De Wilde B, Guerra-García P, Strullu M, Rizzari C, Ek T, Hettmer S, Gerber NU, Rawlings C, Diezi M, Palmu S, Ruggiero A, Verdú J, de Rojas T, Vassal G, Geoerger B, Moreno L and Bautista F.

    Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium

    EUROPEAN JOURNAL OF CANCER . 141: 82-91. Nº de cites: 14

    [doi:10.1016/j.ejca.2020.09.024]

  • Pignata L, Palumbo O, Cerrato F, Acurzio B, de Álava E, Roma J, Gallego S, Mora J, Carella M, Riccio A and Verde G.

    Both Epimutations and Chromosome Aberrations Affect Multiple Imprinted Loci in Aggressive Wilms Tumors

    Cancers . 12(11): . Nº de cites: 6

    [doi:10.3390/cancers12113411]

  • Mora J, Castañeda-Heredia A, Flores MA, Santa-María V, Garraus-Oneca M, Gorostegui M, Simao M, Pérez-Jaume S and Mañe S.

    The Role of Autologous Stem-Cell Transplantation in High-Risk Neuroblastoma Consolidated by anti-GD2 Immunotherapy. Results of Two Consecutive Studies

    FRONTIERS IN PHARMACOLOGY . 11: 575009-575009. Nº de cites: 12

    [doi:10.3389/fphar.2020.575009]

  • Martinez-Lage M, Torres-Ruiz R, Puig-Serra P, Moreno-Gaona P, Martin MC, Moya FJ, Quintana-Bustamante O, Garcia-Silva S, Carcaboso AM, Petazzi P, Bueno C, Mora J, Peinado H, Segovia JC, Menendez P and Rodriguez-Perales S.

    In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells

    NATURE COMMUNICATIONS . 11(1): 5060-5060. Nº de cites: 54

    [doi:10.1038/s41467-020-18875-x]

  • Moisés J, Navarro A, Castellano JJ, Viñolas N, Molins L, Canals J, Han B, Martin-Serrano J, Ramirez J, Frigola G, Marrades RM and Monzó M.

    Long Non-Coding RNA NANCI/NKX2-1 Duplex Impacts Prognosis in Stage I Non-Small-Cell Lung Cancer.

    ARCHIVOS DE BRONCONEUMOLOGIA . 56(10): 630-636. Nº de cites: 2

    [doi:10.1016/j.arbres.2020.01.011]

  • Sánchez-Molina S, Figuerola-Bou E, Blanco ME, Sanchez-Jimenez M, Táboas-Outón P, Gomez-Gonzalez S, Ballaré C, García-Domínguez DJ, Prada-Varela E, Hontecillas-Prieto L, Carcaboso AM, Tirado ÓM, Hernandez-Muñoz MI, de Álava E, Lavarino C, Di Croce L and Mora J.

    RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis

    Science Advances . 6(43): 3058. Nº de cites: 24

    [doi:10.1126/sciadv.aba3058]

  • Tejo-Otero A, Lustig-Gainza P, Fenollosa-Artés F, Valls-Esteve A, Krauel L and Buj-Corral I.

    3D printed soft surgical planning prototype for a biliary tract rhabdomyosarcoma

    Journal of the mechanical behavior of biomedical materials . 109: 103844-103844. Nº de cites: 16

    [doi:10.1016/j.jmbbm.2020.103844]

  • Gadea A, Hernandez-Muñoz MI, Vicente-Villa MA, Andrades E, García-Calvente M, Camacho L, Fernandez-Rodríguez C, Bellosillo B, Pujol R and Toll A.

    Molecular characterisation of oncogenic urothelial mosaic mutations in patients with extensive keratinocytic epidermal naevi.

    JOURNAL OF MEDICAL GENETICS . 57(9): 601-604. Nº de cites: 1

    [doi:10.1136/jmedgenet-2019-106296]

  • Herrero A, Yoshii T, Ispizua JI, Colque C, Veenstra JA, Muraro NI and Ceriani MF.

    Coupling Neuropeptide Levels to Structural Plasticity in Drosophila Clock Neurons.

    CURRENT BIOLOGY . 30(16): . Nº de cites: 14

    [doi:10.1016/j.cub.2020.06.009]

  • Alcon C, Manzano-Muñoz A, Prada-Varela E, Mora J, Soriano A, Guillén G, Gallego S, Roma J, Samitier J, Villanueva A and Montero J.

    Sequential combinations of chemotherapeutic agents with BH3 mimetics to treat rhabdomyosarcoma and avoid resistance

    CELL DEATH & DISEASE . 11(8): 634-634. Nº de cites: 14

    [doi:10.1038/s41419-020-02887-y]